Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Confirmatory Study of APTA-2217 in Patients With Chronic Obstructive Pulmonary Disease (A Placebo-controlled Double-blind Comparative Study)

NCT00242294 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00242294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00242294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Confirmatory Study of APTA-2217 in Patients With Chronic Obstructive Pulmonary Disease (A Placebo-controlled Double-blind Comparative Study)
Lead sponsor
AstraZeneca
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2004
Completion date
March 31, 2007
Enrollment
570
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)